
Publications
2026 up-to-date
1. Kim JM*, Yang YS, Xie J, Kang CM, Cho YC, Park KH, Gong F, Sato T, Kim BJ, Gao G, and Shim JH*. USP24-dependent STAT2 stabilization mediates physiologic and pathologic bone formation. Cell Death Dis. accepted. *co-corresponding author.
This research identifies the deubiquitinating enzyme USP24 as a pivotal regulator of osteogenesis that stabilizes STAT2 to promote bone formation. The study elucidates how the USP24-STAT2 axis modulates BMP signaling, driving both physiological skeletal development and the pathogenesis of heterotopic ossification (HO). The effective mitigation of ectopic bone formation through USP24 silencing in FOP mouse models underscores the therapeutic potential of targeting this signaling pathway to treat debilitating ossification disorders.
2. Kang CM and Kim JM. The posttranslational modification landscape of transcription factors in osteoblast differentiation and bone formation. Life Sci. 2026 Jun 1:394:124365.
This review highlights the critical roles of master transcription factors RUNX2 and Osterix in driving osteoblast commitment, proliferation, differentiation and bone homeostasis. Also it focuses on how posttranslational modifications, such as phosphorylation, ubiquitination and acetylation modulates interactions and stability of these factors during osteoblast development. Ultimately the paper suggests that targeting PTM-mediated regulatory pathways has therapeutic potential for treating various skeletal disorders.
